• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

眼见为实:神经影像学加深了我们对脑部病理学的理解。

Seeing is believing: neuroimaging adds to our understanding of cerebral pathology.

作者信息

Small Gary W, Kepe Vladimir, Barrio Jorge R

机构信息

Department of Psychiatry and Biobehavioral Sciences and Semel Institute for Neuroscience and Human Behavior, Alzheimer's Disease Center, University of California, Los Angeles, California 90024, USA.

出版信息

Curr Opin Psychiatry. 2006 Nov;19(6):564-9. doi: 10.1097/01.yco.0000245747.53008.e2.

DOI:10.1097/01.yco.0000245747.53008.e2
PMID:17012932
Abstract

PURPOSE OF REVIEW

Recent technological developments in neuroimaging have led to new technologies that provide measures of the cerebral pathology of neurodegeneration in living humans. The purpose of this review is to provide background behind these developments and update readers on new findings.

RECENT FINDINGS

Several imaging methods using positron emission tomography have provided measures of amyloid senile plaques in the brain of demented patients and patients with early memory symptoms. ([F-18]FDDNP)-positron emission tomography provides measures of both amyloid plaques and neurofibrillary tangles. Initial results indicate that the pattern of binding values in Alzheimer's disease is consistent with the known neuropathology from autopsy studies, and patients with mild cognitive impairment, who are at risk of Alzheimer's disease, show binding values intermediate between Alzheimer's disease and normal aging. 2-(1-{6-[(2-[F-18]Fluoroethyl)(methyl)amino]-2-naphthyl}ethylidene)malononitrile ([F-18]FDDNP) positron emission tomography also shows a pattern of neuropathology distribution for frontotemporal dementia that differs from that of Alzheimer's disease.

SUMMARY

In-vivo imaging of cerebral pathology offers the potential for more effective and earlier diagnosis and use of these technologies as surrogate markers to test novel treatments aimed at preventing or eliminating cerebral plaque and tangle accumulation.

摘要

综述目的

神经影像学领域最近的技术发展催生了一些新技术,这些技术能够对活体人类神经退行性变的脑病理学特征进行测量。本综述旨在介绍这些技术发展背后的背景知识,并向读者更新新的研究发现。

最新发现

几种使用正电子发射断层扫描的成像方法已能测量痴呆患者及有早期记忆症状患者大脑中的淀粉样老年斑。([F-18]FDDNP)-正电子发射断层扫描可同时测量淀粉样斑块和神经原纤维缠结。初步结果表明,阿尔茨海默病的结合值模式与尸检研究中已知的神经病理学特征一致,而有患阿尔茨海默病风险的轻度认知障碍患者的结合值介于阿尔茨海默病患者和正常衰老者之间。2-(1-{6-[(2-[F-18]氟乙基)(甲基)氨基]-2-萘基}亚乙基)丙二腈([F-18]FDDNP)正电子发射断层扫描还显示了额颞叶痴呆的神经病理学分布模式与阿尔茨海默病不同。

总结

脑病理学的活体成像为更有效、更早期的诊断提供了可能,并有望将这些技术用作替代标志物,以测试旨在预防或消除脑斑块和缠结积聚的新型治疗方法。

相似文献

1
Seeing is believing: neuroimaging adds to our understanding of cerebral pathology.眼见为实:神经影像学加深了我们对脑部病理学的理解。
Curr Opin Psychiatry. 2006 Nov;19(6):564-9. doi: 10.1097/01.yco.0000245747.53008.e2.
2
PET of brain amyloid and tau in mild cognitive impairment.轻度认知障碍患者脑淀粉样蛋白和tau蛋白的正电子发射断层显像(PET)
N Engl J Med. 2006 Dec 21;355(25):2652-63. doi: 10.1056/NEJMoa054625.
3
Multitracer PET imaging of amyloid plaques and neurofibrillary tangles in Alzheimer's disease.阿尔茨海默病中淀粉样斑块和神经原纤维缠结的多示踪剂PET成像。
Neuroimage. 2008 Nov 1;43(2):236-44. doi: 10.1016/j.neuroimage.2008.07.022. Epub 2008 Jul 23.
4
Visualizing pathology deposits in the living brain of patients with Alzheimer's disease.可视化阿尔茨海默病患者活体大脑中的病理沉积物。
Methods Enzymol. 2006;412:144-60. doi: 10.1016/S0076-6879(06)12010-8.
5
The merits of FDDNP-PET imaging in Alzheimer's disease.FDDNP-PET 成像在阿尔茨海默病中的优点。
J Alzheimers Dis. 2011;26 Suppl 3:135-45. doi: 10.3233/JAD-2011-0008.
6
Plaque and tangle imaging and cognition in normal aging and Alzheimer's disease.斑块和缠结成像与正常衰老及阿尔茨海默病认知。
Neurobiol Aging. 2010 Oct;31(10):1669-78. doi: 10.1016/j.neurobiolaging.2008.09.012. Epub 2008 Nov 11.
7
Modifiable Risk Factors and Brain Positron Emission Tomography Measures of Amyloid and Tau in Nondemented Adults with Memory Complaints.有记忆障碍的非痴呆成年人中可改变的风险因素以及淀粉样蛋白和tau蛋白的脑正电子发射断层扫描测量
Am J Geriatr Psychiatry. 2016 Sep;24(9):729-37. doi: 10.1016/j.jagp.2016.05.007. Epub 2016 May 13.
8
Binding characteristics of radiofluorinated 6-dialkylamino-2-naphthylethylidene derivatives as positron emission tomography imaging probes for beta-amyloid plaques in Alzheimer's disease.放射性氟化6-二烷基氨基-2-萘基亚乙基衍生物作为阿尔茨海默病中β-淀粉样斑块正电子发射断层显像探针的结合特性
J Neurosci. 2001 Dec 15;21(24):RC189. doi: 10.1523/JNEUROSCI.21-24-j0004.2001.
9
Localization of neurofibrillary tangles and beta-amyloid plaques in the brains of living patients with Alzheimer disease.阿尔茨海默病在世患者大脑中神经原纤维缠结和β-淀粉样蛋白斑块的定位
Am J Geriatr Psychiatry. 2002 Jan-Feb;10(1):24-35.
10
Assessment of dementia risk in aging adults using both FDG-PET and FDDNP-PET imaging.使用 FDG-PET 和 FDDNP-PET 成像评估老年人群的痴呆风险。
Int J Geriatr Psychiatry. 2012 Oct;27(10):1017-27. doi: 10.1002/gps.2816. Epub 2012 Mar 1.

引用本文的文献

1
SSRIs reduce plasma tau and restore dorsal raphe metabolism in Alzheimer's disease.选择性5-羟色胺再摄取抑制剂(SSRIs)可降低阿尔茨海默病患者的血浆tau蛋白水平并恢复中缝背核的代谢。
Alzheimers Dement. 2025 Feb;21(2):e14579. doi: 10.1002/alz.14579.
2
CSF amino acid profiles in ICV-streptozotocin-induced sporadic Alzheimer's disease in male Wistar rat: a metabolomics and systems biology perspective.CSF 氨基酸谱在雄性 Wistar 大鼠脑室内注射链脲佐菌素诱导的散发性阿尔茨海默病中的变化:代谢组学和系统生物学视角。
FEBS Open Bio. 2024 Jul;14(7):1116-1132. doi: 10.1002/2211-5463.13814. Epub 2024 May 20.
3
Metabolic Pathway Pairwise-Based Signature as a Potential Non-Invasive Diagnostic Marker in Alzheimer's Disease Patients.
基于代谢途径对的特征作为阿尔茨海默病患者潜在的非侵入性诊断标志物。
Genes (Basel). 2023 Jun 17;14(6):1285. doi: 10.3390/genes14061285.
4
Metabolomic Footprint of Disrupted Energetics and Amino Acid Metabolism in Neurodegenerative Diseases: Perspectives for Early Diagnosis and Monitoring of Therapy.神经退行性疾病中能量代谢和氨基酸代谢紊乱的代谢组学特征:早期诊断和治疗监测的前景
Metabolites. 2023 Mar 1;13(3):369. doi: 10.3390/metabo13030369.
5
Metabolic Dysregulation Contributes to the Progression of Alzheimer's Disease.代谢失调促进阿尔茨海默病的进展。
Front Neurosci. 2020 Nov 5;14:530219. doi: 10.3389/fnins.2020.530219. eCollection 2020.
6
Dementia spectrum disorders: lessons learnt from decades with PET research.痴呆谱系障碍:从数十年的 PET 研究中吸取的经验教训。
J Neural Transm (Vienna). 2019 Mar;126(3):233-251. doi: 10.1007/s00702-019-01975-4. Epub 2019 Feb 14.
7
Alzheimer's Disease: Fatty Acids We Eat may be Linked to a Specific Protection via Low-dose Aspirin.阿尔茨海默病:我们吃的脂肪酸可能通过低剂量阿司匹林与特定保护作用有关。
Aging Dis. 2010 Aug;1(1):37-59. Epub 2010 Jul 12.
8
PET/CT in diagnosis of dementia.正电子发射断层扫描/计算机断层扫描在痴呆诊断中的应用。
Ann N Y Acad Sci. 2011 Jun;1228:81-92. doi: 10.1111/j.1749-6632.2011.06015.x.
9
Decreased levels of PSD95 and two associated proteins and increased levels of BCl2 and caspase 3 in hippocampus from subjects with amnestic mild cognitive impairment: Insights into their potential roles for loss of synapses and memory, accumulation of Abeta, and neurodegeneration in a prodromal stage of Alzheimer's disease.遗忘型轻度认知障碍患者海马体中 PSD95 及其两种相关蛋白水平降低,BCL2 和 caspase 3 水平升高:提示它们在阿尔茨海默病前驱期突触和记忆丧失、β淀粉样蛋白积累以及神经退行性变中的潜在作用。
J Neurosci Res. 2010 Feb 15;88(3):469-77. doi: 10.1002/jnr.22227.
10
Altered neuronal gene expression in brain regions differentially affected by Alzheimer's disease: a reference data set.阿尔茨海默病不同程度影响的脑区中神经元基因表达的改变:一个参考数据集
Physiol Genomics. 2008 Apr 22;33(2):240-56. doi: 10.1152/physiolgenomics.00242.2007. Epub 2008 Feb 12.